E.M. Noordijk

3.9k total citations
50 papers, 2.8k citations indexed

About

E.M. Noordijk is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, E.M. Noordijk has authored 50 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 20 papers in Pulmonary and Respiratory Medicine and 20 papers in Oncology. Recurrent topics in E.M. Noordijk's work include Lymphoma Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (14 papers) and CNS Lymphoma Diagnosis and Treatment (11 papers). E.M. Noordijk is often cited by papers focused on Lymphoma Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (14 papers) and CNS Lymphoma Diagnosis and Treatment (11 papers). E.M. Noordijk collaborates with scholars based in Netherlands, France and Belgium. E.M. Noordijk's co-authors include Hanneke C. Kluin‐Nelemans, José Thomas, Patrice Carde, M. Henry‐Amar, Augustinus D. G. Krol, J.W.H. Leer, Ivana Teodorović, Corrie A.M. Marijnen, Simone Snijder and J.H. Meerwaldt and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

E.M. Noordijk

50 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.M. Noordijk Netherlands 26 1.9k 1.3k 742 600 494 50 2.8k
R. Somers Netherlands 26 1.7k 0.9× 1.1k 0.9× 1.2k 1.7× 524 0.9× 486 1.0× 65 2.9k
Massimo Magagnoli Italy 26 1.8k 1.0× 1.1k 0.8× 519 0.7× 623 1.0× 281 0.6× 83 2.7k
Paul Smith United Kingdom 24 1.9k 1.0× 1.4k 1.1× 780 1.1× 742 1.2× 445 0.9× 66 3.5k
G P Canellos United States 23 2.1k 1.1× 1.2k 0.9× 728 1.0× 806 1.3× 222 0.4× 33 2.8k
Giovanni Serio Italy 15 1.4k 0.8× 1.3k 1.0× 504 0.7× 451 0.8× 497 1.0× 41 2.4k
Woodrow Wells Canada 19 1.3k 0.7× 894 0.7× 465 0.6× 548 0.9× 308 0.6× 43 1.9k
Rolf‐Peter Müller Germany 27 1.2k 0.6× 779 0.6× 1.0k 1.4× 564 0.9× 615 1.2× 56 2.6k
Bouthaina S. Dabaja United States 30 1.5k 0.8× 1.2k 0.9× 820 1.1× 687 1.1× 391 0.8× 144 3.1k
Lillian M. Fuller United States 37 2.9k 1.6× 1.7k 1.3× 1000 1.3× 908 1.5× 667 1.4× 101 4.3k
G. Vaughan Hudson United Kingdom 33 3.1k 1.7× 2.0k 1.5× 915 1.2× 896 1.5× 285 0.6× 66 4.0k

Countries citing papers authored by E.M. Noordijk

Since Specialization
Citations

This map shows the geographic impact of E.M. Noordijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.M. Noordijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.M. Noordijk more than expected).

Fields of papers citing papers by E.M. Noordijk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.M. Noordijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.M. Noordijk. The network helps show where E.M. Noordijk may publish in the future.

Co-authorship network of co-authors of E.M. Noordijk

This figure shows the co-authorship network connecting the top 25 collaborators of E.M. Noordijk. A scholar is included among the top collaborators of E.M. Noordijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.M. Noordijk. E.M. Noordijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaaij, Marleen A. E. van der, Natacha Heutte, Jannie van Echten‐Arends, et al.. (2009). Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials. Haematologica. 94(12). 1691–1697. 49 indexed citations
2.
Jansen-Landheer, M.L.E.A., Pieta Krijnen, E.M. Noordijk, et al.. (2009). Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study. European Journal of Surgical Oncology. 35(12). 1326–1332. 36 indexed citations
3.
Marijnen, Corrie A.M., Irıs D. Nagtegaal, Ellen Kapiteijn, et al.. (2003). Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. International Journal of Radiation Oncology*Biology*Physics. 55(5). 1311–1320. 195 indexed citations
4.
Creutzberg, Carien L., et al.. (2003). Nuclear β‐catenin is a molecular feature of type I endometrial carcinoma. The Journal of Pathology. 201(3). 460–465. 58 indexed citations
5.
Leeuwen, Flora E. van, Willem J. Klokman, Marilyn Stovall, et al.. (2003). Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease. JNCI Journal of the National Cancer Institute. 95(13). 971–980. 286 indexed citations
7.
Krol, Augustinus D. G., Saskia le Cessie, Simone Snijder, et al.. (2002). Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Annals of Oncology. 14(1). 131–139. 193 indexed citations
8.
Raemaekers, John, Hanneke C. Kluin‐Nelemans, Ivana Teodorović, et al.. (2002). The achievements of the EORTC Lymphoma Group. European Journal of Cancer. 38. 107–113. 49 indexed citations
9.
Krol, Augustinus D. G., Saskia le Cessie, Simone Snijder, et al.. (2001). Waldeyer's Ring Lymphomas: A Clinical Study from the Comprehensive Cancer Center West Population Based NHL Registry. Leukemia & lymphoma. 42(5). 1005–1013. 25 indexed citations
10.
Kluin‐Nelemans, Hanneke C., Vittorina Zagonel, Dominique Bron, et al.. (2001). Standard Chemotherapy With or Without High-Dose Chemotherapy for Aggressive Non-Hodgkin's Lymphoma: Randomized Phase III EORTC Study. JNCI Journal of the National Cancer Institute. 93(1). 22–30. 106 indexed citations
11.
Maartense, E., J. Hermans, Hanneke C. Kluin‐Nelemans, et al.. (1998). Elderly patients with non-Hodgkin’s lymphoma: Population-based results in the Netherlands. Annals of Oncology. 9(11). 1219–1227. 45 indexed citations
12.
Ong, F., J. Hermans, E.M. Noordijk, et al.. (1997). Developing a population-based registry for patients with paraproteinemias or multiple myeloma. Journal of Clinical Epidemiology. 50(8). 909–915. 7 indexed citations
13.
Velders, Gerjo A., Hanneke C. Kluin‐Nelemans, Carla J. de Boer, et al.. (1996). Mantle-cell lymphoma. Journal of Clinical Oncology. 14(4). 3 indexed citations
14.
Rijlaarsdam, J. U., Johan Toonstra, Otto W.M. Meijer, E.M. Noordijk, & Rein Willemze. (1996). Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy.. Journal of Clinical Oncology. 14(2). 549–555. 104 indexed citations
15.
Teodorović, Ivana, Stefania Pittaluga, Hanneke C. Kluin‐Nelemans, et al.. (1995). Efficacy of four different regimens in 64 mantle-cell lymphoma cases. Journal of Clinical Oncology. 13(11). 4 indexed citations
16.
Ong, F., J. Hermans, E.M. Noordijk, & Hanneke C. Kluin‐Nelemans. (1995). Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice?. Annals of Hematology. 70(1). 19–24. 12 indexed citations
17.
Bodis, Stephan, M. Henry‐Amar, J. Bosq, et al.. (1993). Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.. Journal of Clinical Oncology. 11(2). 225–232. 42 indexed citations
18.
Leer, J.W.H. & E.M. Noordijk. (1992). Training in radiotherapy in the Netherlands. International Journal of Radiation Oncology*Biology*Physics. 24(5). 837–839. 4 indexed citations
19.
Henry‐Amar, M., M. Hayat, J.H. Meerwaldt, et al.. (1990). Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. International Journal of Radiation Oncology*Biology*Physics. 19(5). 1155–1157. 80 indexed citations
20.
Schaafsma, M, et al.. (1987). Staging and treatment of non‐Hodgkin's lymphoma of intermediate‐grade malignancy: A retrospectective study of 102 cases. European Journal Of Haematology. 39(3). 252–258. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026